Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
November-2019 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2019 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension

  • Authors:
    • Leandro Ricardo Ferraz
    • Bianca Caruso Moreira
    • Gabriela de Souza Rodrigues de Queiroz
    • Regiane de Freitas Formigari
    • Marcelo Augusto Marreto Esquisatto
    • Maira Felonato
    • Armindo Antonio Alves
    • Bruna Fontana Thomazini
    • Camila Andréa de Oliveira
  • View Affiliations / Copyright

    Affiliations: Graduate Program in Biomedical Sciences, University Center of the Hermínio Ometto Foundation, Araras, São Paulo 13607-339, Brazil
    Copyright: © Ferraz et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4467-4476
    |
    Published online on: October 2, 2019
       https://doi.org/10.3892/mmr.2019.10722
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Epithelial-to-mesenchymal transition (EMT) and endothelial-to-mesenchymal transition are processes that can occur under different biological conditions, including tissue healing due to hypertension and oxidative stress. The purpose of the present study was to evaluate the differences in gene expression of epithelial/endothelial and mesenchymal markers in different tissues. A two-kidney, one-clip (2K1C) renovascular hypertension rat model was used. Hypertension was induced by the clipping of the left renal artery; the rats were randomized into sham and 2K1C groups and monitored for up to 4 weeks. The gene expressions of E-cadherin (E-cad), N-cadherin (N-cad), α-smooth muscle actin (α-SMA), collagen I (COL1A1), collagen III (COL3A1) and hepatocyte growth factor (HGF) were determined by reverse transcription-PCR. The levels of the cytokines transforming growth factor-β1, tumor necrosis factor-α, interleukin (IL)-4, IL-6 and IL-10 were evaluated using ELISAs. The levels of thiobarbituric acid reactive substances and thiol groups were measured to evaluate oxidative stress. All analyses were performed on the liver, heart and kidneys tissues of sham and model rats. The 2K1C animals exhibited a higher systolic blood pressure, as well as cardiac hypertrophy and atrophy of the left kidney. Fibrotic alterations in the heart and kidneys were observed, as was an increase in the collagen fiber areas, and higher levels of inflammatory cytokines, which are associated with the increased expression of fibroproliferative and anti-fibrotic genes. Renovascular hypertension regulated epithelial/endothelial and mesenchymal markers, including E-cad, N-cad, α-SMA and COL1A1 in the kidneys and heart. EMT in the kidneys was mediated by an increased level of inflammatory and profibrotic cytokines, as well as by oxidative stress. The data in the present study suggested that the expression of epithelial/endothelial and mesenchymal markers are differentially regulated by hypertension in the liver, heart and kidneys.
View Figures

Figure 1

Figure 2

View References

1 

Levy D, Larson MG, Vasan RS, Kannel WB and Ho KK: The progression from hypertension to congestive heart failure. JAMA. 275:1557–1562. 1996. View Article : Google Scholar : PubMed/NCBI

2 

Khangura KK, Eirin A, Kane GC, Misra S, Textor SC, Lerman A and Lerman LO: Cardiac function in renovascular hypertensive patients with and without renal dysfunction. Am J Hypertens. 27:445–453. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Chade AR, Rodriguez-Porcel M, Grande JP, Krier JD, Lerman A, Romero JC, Napoli C and Lerman LO: Distinct renal injury in early atherosclerosis and renovascular disease. Circulation. 106:1165–1171. 2002. View Article : Google Scholar : PubMed/NCBI

4 

Crowley SD: The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal. 20:102–120. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnikoff MS, Bergamaschi CT and Campos RR: Oxidative stress contributes to renovascular hypertension. Am J Hypertens. 21:98–104. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Lim YS, Lee HC and Lee HS: Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells. Histochem Cell Biol. 127:149–160. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Wu M, Peng Z, Zu C, Ma J, Lu S, Zhong J and Zhang S: Losartan attenuates myocardial endothelial-to-mesenchymal transition in spontaneous hypertensive rats via inhibiting TGF-β/Smad signaling. PLoS One. 11:e01557302016. View Article : Google Scholar : PubMed/NCBI

8 

Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A and Lerman LO: Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens. 26:1651–1660. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Fragiadaki M and Mason RM: Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int J Exp Pathol. 92:143–150. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Niessen CM, Leckband D and Yap AS: Tissue organization by cadherin adhesion molecules: Dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol Rev. 91:691–731. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Katsamba P, Carroll K, Ahlsen G, Bahna F, Vendome J, Posy S, Rajebhosale M, Price S, Jessell TM, Ben-Shaul A, et al: Linking molecular affinity and cellular specificity in cadherin-mediated adhesion. Proc Natl Acad Sci USA. 106:11594–11599. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Gumbiner BM: Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell. 84:345–357. 1996. View Article : Google Scholar : PubMed/NCBI

13 

Murphy F, Waung J, Collins J, Arthur MJ, Nagase H, Mann D, Benyon RC and Iredale JP: N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol. 3 (Suppl 1):S82004. View Article : Google Scholar : PubMed/NCBI

14 

Guarino M, Tosoni A and Nebuloni M: Direct contribution of epithelium to organ fibrosis: Epithelial-mesenchymal transition. Hum Pathol. 40:1365–1376. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Voutsadakis IA: HER2 in stemness and epithelial-mesenchymal plasticity of breast cancer. Clin Transl Oncol. 21:539–555. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Wang H and Unternaehrer JJ: Epithelial-mesenchymal transition and cancer stem cells: At the crossroads of differentiation and dedifferentiation. Dev Dyn. 248:10–20. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Yu K, Li Q, Shi G and Li N: Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi J Gastroenterol. 24:5–11. 2018. View Article : Google Scholar : PubMed/NCBI

18 

Chen DQ, Feng YL, Cao G and Zhao YY: Natural products as a source for antifibrosis therapy. Trends Pharmacol Sci. 39:937–952. 2018. View Article : Google Scholar : PubMed/NCBI

19 

Goldblatt H, Lynch J, Hanzal RF and Summerville WW: Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 59:347–379. 1934. View Article : Google Scholar : PubMed/NCBI

20 

Esterbauer H and Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:407–421. 1990. View Article : Google Scholar : PubMed/NCBI

21 

Faure P and Lafond JL: Measurement of plasma sulfhydryl and carbonyl groups as a possible indicator of protein oxidationAnalysis of Free Radicals in Biological Systems. Favier AE, Cadet J, Kalyanaraman B, Fontecave M and Pierre JL: Birkhäuser; Basel: pp. 237–248. 1995, View Article : Google Scholar

22 

Hiyoshi H, Yayama K, Takano M and Okamoto H: Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension. 45:967–973. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Mehta PK and Griendling KK: Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 292:C82–C97. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Janicki JS, Brower GL, Gardner JD, Chancey AL and Stewart JA Jr: The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling. Heart Fail Rev. 9:33–42. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Peotta VA, Gava AL, Vasquez EC and Meyrelles SS: Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Can J Physiol Pharmacol. 85:761–766. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Ding Y and Choi ME: Regulation of autophagy by TGF-β: Emerging role in kidney fibrosis. Semin Nephrol. 34:62–71. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Singh MV, Chapleau MW, Harwani SC and Abboud FM: The immune system and hypertension. Immunol Res. 59:243–253. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE and Brower GL: Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension. 53:1041–1047. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Matavelli LC, Huang J and Siragy HM: Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension. 57:308–313. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Endtmann C, Ebrahimian T, Czech T, Arfa O, Laufs U, Fritz M, Wassmann K, Werner N, Petoumenos V, Nickenig G and Wassmann S: Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: Implications for vascular regeneration. Hypertension. 58:394–403. 2011. View Article : Google Scholar : PubMed/NCBI

31 

Skultetyova D, Filipova S, Riecansky I and Skultety J: The role of angiotensin type 1 receptor in inflammation and endothelial dysfunction. Recent Pat Cardiovasc Drug Discov. 2:23–27. 2007. View Article : Google Scholar : PubMed/NCBI

32 

Polizio AH and Peña C: Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues. Regul Pept. 128:1–5. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Dornas WC, Silva M, Tavares R, de Lima WG, dos Santos RC, Pedrosa ML and Silva ME: Efficacy of the superoxide dismutase mimetic tempol in animal hypertension models: A meta-analysis. J Hypertens. 33:14–23. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Rizzi E, Ceron CS, Guimaraes DA, Prado CM, Rossi MA, Gerlach RF and Tanus-Santos JE: Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. Exp Mol Pathol. 94:1–9. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Seif HSA: Physiological changes due to hepatotoxicity and the protective role of some medicinal plants. Beni-Suef Univ J Basic Appl Sci. 5:134–146. 2016. View Article : Google Scholar

36 

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M and Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84. 2007. View Article : Google Scholar : PubMed/NCBI

37 

Correa-Costa M, Semedo P, Monteiro AP, Silva RC, Pereira RL, Gonçalves GM, Marques GD, Cenedeze MA, Faleiros AC, Keller AC, et al: Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One. 5:e142982010. View Article : Google Scholar : PubMed/NCBI

38 

Genovese F, Manresa AA, Leeming DJ, Karsdal MA and Boor P: The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis Tissue Repair. 7:42014. View Article : Google Scholar : PubMed/NCBI

39 

Lovisa S, LeBleu VS, Tampe B, Sugimoto H, Vadnagara K, Carstens JL, Wu CC, Hagos Y, Burckhardt BC, Pentcheva-Hoang T, et al: Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 21:998–1009. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Wang Y, Pang L, Zhang Y, Lin J and Zhou H: Fenofibrate improved interstitial fibrosis of renal allograft through inhibited epithelial-mesenchymal transition induced by oxidative stress. Oxid Med Cell Longev. 2019:89368562019.PubMed/NCBI

41 

Chen Y, Luo Q and Xiong Z, Liang W, Chen L and Xiong Z: Telmisartan counteracts TGF-β1 induced epithelial-to-mesenchymal transition via PPAR-γ in human proximal tubule epithelial cells. Int J Clin Exp Pathol. 5:522–529. 2012.PubMed/NCBI

42 

Liu M, Liu L, Bai M, Zhang L, Ma F, Yang X and Sun S: Hypoxia-induced activation of Twist/miR-214/E-cadherin axis promotes renal tubular epithelial cell mesenchymal transition and renal fibrosis. Biochem Biophys Res Commun. 495:2324–2330. 2018. View Article : Google Scholar : PubMed/NCBI

43 

Nieto MA and Cano A: The epithelial-mesenchymal transition under control: Global programs to regulate epithelial plasticity. Semin Cancer Biol. 22:361–368. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Wang Y, Mu JJ, Liu FQ, Ren KY, Xiao HY, Yang Z and Yuan ZY: Salt-induced epithelial-to-mesenchymal transition in Dahl salt-sensitive rats is dependent on elevated blood pressure. Braz J Med Biol Res. 47:223–230. 2014. View Article : Google Scholar : PubMed/NCBI

45 

dos Santos DO, Blefari V, Prado FP, Silva CA, Fazan R Jr, Salgado HC, Ramos SG and Prado CM: Reduced expression of adherens and gap junction proteins can have a fundamental role in the development of heart failure following cardiac hypertrophy in rats. Exp Mol Pathol. 100:167–176. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Liu G, Liang B, Song X, Bai R, Qin W, Sun X, Lu Y, Bian Y and Xiao C: P-selectin increases angiotensin II-induced cardiac inflammation and fibrosis via platelet activation. Mol Med Rep. 13:5021–5028. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Canel M, Serrels A, Anderson KI, Frame MC and Brunton VG: Use of photoactivation and photobleaching to monitor the dynamic regulation of E-cadherin at the plasma membrane. Cell Adh Migr. 4:491–501. 2010. View Article : Google Scholar : PubMed/NCBI

48 

Okayama K, Azuma J, Dosaka N, Iekushi K, Sanada F, Kusunoki H, Iwabayashi M, Rakugi H, Taniyama Y and Morishita R: Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition. Hypertension. 59:958–965. 2012. View Article : Google Scholar : PubMed/NCBI

49 

Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G and Jiang X: Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 34:381–390. 2014. View Article : Google Scholar : PubMed/NCBI

50 

Nieto MA, Huang RY, Jackson RA and Thiery JP: Emt: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI

51 

Jolly MK, Ward C, Eapen MS, Myers S, Hallgren O, Levine H and Sohal SS: Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease. Dev Dyn. 247:346–358. 2018. View Article : Google Scholar : PubMed/NCBI

52 

Jones CN, Tuleuova N, Lee JY, Ramanculov E, Reddi AH, Zern MA and Revzin A: Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury. Biomaterials. 31:5936–5944. 2010. View Article : Google Scholar : PubMed/NCBI

53 

Xie G and Diehl AM: Evidence for and against epithelial-to-mesenchymal transition in the liver. Am J Physiol Gastrointest Liver Physiol. 305:G881–G890. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ferraz LR, Moreira BC, de Queiroz Gd, Formigari Rd, Esquisatto MA, Felonato M, Alves AA, Thomazini BF and de Oliveira CA: Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension. Mol Med Rep 20: 4467-4476, 2019.
APA
Ferraz, L.R., Moreira, B.C., de Queiroz, G.d., Formigari, R.d., Esquisatto, M.A., Felonato, M. ... de Oliveira, C.A. (2019). Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension. Molecular Medicine Reports, 20, 4467-4476. https://doi.org/10.3892/mmr.2019.10722
MLA
Ferraz, L. R., Moreira, B. C., de Queiroz, G. d., Formigari, R. d., Esquisatto, M. A., Felonato, M., Alves, A. A., Thomazini, B. F., de Oliveira, C. A."Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension". Molecular Medicine Reports 20.5 (2019): 4467-4476.
Chicago
Ferraz, L. R., Moreira, B. C., de Queiroz, G. d., Formigari, R. d., Esquisatto, M. A., Felonato, M., Alves, A. A., Thomazini, B. F., de Oliveira, C. A."Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension". Molecular Medicine Reports 20, no. 5 (2019): 4467-4476. https://doi.org/10.3892/mmr.2019.10722
Copy and paste a formatted citation
x
Spandidos Publications style
Ferraz LR, Moreira BC, de Queiroz Gd, Formigari Rd, Esquisatto MA, Felonato M, Alves AA, Thomazini BF and de Oliveira CA: Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension. Mol Med Rep 20: 4467-4476, 2019.
APA
Ferraz, L.R., Moreira, B.C., de Queiroz, G.d., Formigari, R.d., Esquisatto, M.A., Felonato, M. ... de Oliveira, C.A. (2019). Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension. Molecular Medicine Reports, 20, 4467-4476. https://doi.org/10.3892/mmr.2019.10722
MLA
Ferraz, L. R., Moreira, B. C., de Queiroz, G. d., Formigari, R. d., Esquisatto, M. A., Felonato, M., Alves, A. A., Thomazini, B. F., de Oliveira, C. A."Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension". Molecular Medicine Reports 20.5 (2019): 4467-4476.
Chicago
Ferraz, L. R., Moreira, B. C., de Queiroz, G. d., Formigari, R. d., Esquisatto, M. A., Felonato, M., Alves, A. A., Thomazini, B. F., de Oliveira, C. A."Tissue-specific transcriptional regulation of epithelial/endothelial and mesenchymal markers during renovascular hypertension". Molecular Medicine Reports 20, no. 5 (2019): 4467-4476. https://doi.org/10.3892/mmr.2019.10722
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team